Kelly E. Carstens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kelly E. Carstens has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Katie Paul Friedman
Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA
4 shared publications - Barbara A. Wetmore
Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency (USEPA), Durham, NC 27709, USA
3 shared publications - Joshua A. Harrill
Corteva Agriscience, Indianapolis, USA
3 shared publications - Stephanie Padilla
Center for Computational Toxicology and Exposure, Biomolecular and Computational Toxicology Division, Rapid Assay Development Branch, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA
3 shared publications - Timothy J. Shafer
U.S. Environmental Protection Agency
3 shared publications - Ann M. Richard
U.S. Environmental Protection Agency
2 shared publications
Latest Publications
- 15 October 2025
- Published by Elsevier in NeuroToxicology
- Vol. 111, 103328
Development of a network formation assay for developmental neurotoxicity hazard screening using 3D human iPSC derived BrainSpheres
- 15 October 2025
- Published by Elsevier in NeuroToxicology
- Vol. 111, 103328
Development of a network formation assay for developmental neurotoxicity hazard screening using 3D human iPSC derived BrainSpheres
- Open Access
- 10 September 2025
- Published by Elsevier in SLAS Technology
- Vol. 35, 100347
High-throughput cytokine detection platform for evaluation of chemical induced microglial activation
- 10 September 2025
- Published by Elsevier in SLAS Technology
- Vol. 35, 100347
Open AccessHigh-throughput cytokine detection platform for evaluation of chemical induced microglial activation
- 23 August 2025
- Published by Elsevier in Toxicology
- Vol. 518, 154266
Development of a multiplexed, high content imaging-based assay for assessing chemical effects on proliferation and apoptosis in human neural progenitor cells
- 23 August 2025
- Published by Elsevier in Toxicology
- Vol. 518, 154266
Development of a multiplexed, high content imaging-based assay for assessing chemical effects on proliferation and apoptosis in human neural progenitor cells
- 6 July 2025
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part B
- Vol. 29 (1) , 1-69
Insights derived from testing a library of per- and polyfluoroalkyl substances (PFAS) in a battery of new approach methods (NAMs)
Per- and polyfluoroalkyl substances (PFAS) comprise a large class of human-made chemicals that are in widespread use and present concerns for persistence, bioaccumulation and toxicity. Whilst a handful of PFAS have been characterized for their hazard profiles, the vast majority of PFAS have not been extensively studied. A comprehensive evaluation to characterize the hazard profiles of the thousands of available PFAS would require extensive resources in terms of cost, number of animals and time. An alternative and more efficient approach is to develop a structural chemical categorization approach to prioritize which PFAS or categories of PFAS should be subject to additional study. To that end, the U.S. Environmental Protection Agency (EPA), in collaboration with the National Institute of Environmental Health Sciences (NIEHS) Division of Translational Toxicology (DTT), initiated a research project in 2018 to screen approximately 150 PFAS through a battery of alternative model organisms, in vitro cell and biochemical assays, and in vitro toxico kinetic (TK) assays in order to inform chemical category and read-across approaches. The aim of this review summarizes the experimental testing undertaken, how data were processed, what insights were derived from a category perspective and how these might potentially inform subsequent tiered testing.
- 6 July 2025
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part B
- Vol. 29 (1) , 1-69
Insights derived from testing a library of per- and polyfluoroalkyl substances (PFAS) in a battery of new approach methods (NAMs)
Per- and polyfluoroalkyl substances (PFAS) comprise a large class of human-made chemicals that are in widespread use and present concerns for persistence, bioaccumulation and toxicity. Whilst a handful of PFAS have been characterized for their hazard profiles, the vast majority of PFAS have not been extensively studied. A comprehensive evaluation to characterize the hazard profiles of the thousands of available PFAS would require extensive resources in terms of cost, number of animals and time. An alternative and more efficient approach is to develop a structural chemical categorization approach to prioritize which PFAS or categories of PFAS should be subject to additional study. To that end, the U.S. Environmental Protection Agency (EPA), in collaboration with the National Institute of Environmental Health Sciences (NIEHS) Division of Translational Toxicology (DTT), initiated a research project in 2018 to screen approximately 150 PFAS through a battery of alternative model organisms, in vitro cell and biochemical assays, and in vitro toxico kinetic (TK) assays in order to inform chemical category and read-across approaches. The aim of this review summarizes the experimental testing undertaken, how data were processed, what insights were derived from a category perspective and how these might potentially inform subsequent tiered testing.
- Open Access
- 26 June 2025
- Published by Elsevier in NAM Journal
- Vol. 1, 100033
A data analysis approach for locomotor behavioral responses in developmentally exposed zebrafish
- 26 June 2025
- Published by Elsevier in NAM Journal
- Vol. 1, 100033
Open AccessA data analysis approach for locomotor behavioral responses in developmentally exposed zebrafish
- Open Access
Development of a network formation assay for developmental neurotoxicity hazard screening using 3D human iPSC derived BrainSpheres
Exposure of the developing brain to environmental neurotoxicants can result in permanent alterations in structure and/or function. To investigate the effects of chemical exposures on neurodevelopment, the human induced-pluripotent stem cell (iPSC)-derived neural BrainSphere model has been utilized due to its ability to form mature neuronal populations and exhibit spontaneous electrical activity. To model network formation for developmental neurotoxicity screening, developing BrainSpheres were plated on high-density microelectrode arrays (hdMEA) three weeks after beginning differentiation. Starting two days post-plating, BrainSpheres were treated three times per week with compounds known to disrupt in vitro network formation (i.e. assay positive controls; loperamide, dieldrin and deltamethrin), or with an assay negative control, glyphosate, expected to have no effect. For 29 days, BrainSphere activity was recorded to measure neural network activity, general activity, and features of action potential propagation. Concentration-dependent disruption in neural network formation was observed for positive controls at concentrations below cytotoxicity. Dieldrin, deltamethrin, and loperamide exposure disrupted several features of general activity, neural network formation, and action potential propagation. BrainSpheres on hdMEAs detected chemically induced perturbations in neural network formation and may represent a valuable complex in vitro model useful for developmental neurotoxicity screening.
Open AccessDevelopment of a network formation assay for developmental neurotoxicity hazard screening using 3D human iPSC derived BrainSpheres
Exposure of the developing brain to environmental neurotoxicants can result in permanent alterations in structure and/or function. To investigate the effects of chemical exposures on neurodevelopment, the human induced-pluripotent stem cell (iPSC)-derived neural BrainSphere model has been utilized due to its ability to form mature neuronal populations and exhibit spontaneous electrical activity. To model network formation for developmental neurotoxicity screening, developing BrainSpheres were plated on high-density microelectrode arrays (hdMEA) three weeks after beginning differentiation. Starting two days post-plating, BrainSpheres were treated three times per week with compounds known to disrupt in vitro network formation (i.e. assay positive controls; loperamide, dieldrin and deltamethrin), or with an assay negative control, glyphosate, expected to have no effect. For 29 days, BrainSphere activity was recorded to measure neural network activity, general activity, and features of action potential propagation. Concentration-dependent disruption in neural network formation was observed for positive controls at concentrations below cytotoxicity. Dieldrin, deltamethrin, and loperamide exposure disrupted several features of general activity, neural network formation, and action potential propagation. BrainSpheres on hdMEAs detected chemically induced perturbations in neural network formation and may represent a valuable complex in vitro model useful for developmental neurotoxicity screening.
- 23 May 2024
- Published by Elsevier in Toxicology
- Vol. 505, 153842
Chemical effects on neural network activity: Comparison of acute versus network formation exposure in microelectrode array assays
- 23 May 2024
- Published by Elsevier in Toxicology
- Vol. 505, 153842
Chemical effects on neural network activity: Comparison of acute versus network formation exposure in microelectrode array assays
- Open Access
A Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS)
Per- and polyfluoroalkyl substances (PFAS) are widely used, and their fluorinated state contributes to unique uses and stability but also long half-lives in the environment and humans. PFAS have been shown to be toxic, leading to immunosuppression, cancer, and other adverse health outcomes. Only a small fraction of the PFAS in commerce have been evaluated for toxicity using in vivo tests, which leads to a need to prioritize which compounds to examine further. Here, we demonstrate a prioritization approach that combines human biomonitoring data (blood concentrations) with bioactivity data (concentrations at which bioactivity is observed in vitro) for 31 PFAS. The in vitro data are taken from a battery of cell-based assays, mostly run on human cells. The result is a Bioactive Concentration to Blood Concentration Ratio (BCBCR), similar to a margin of exposure (MoE). Chemicals with low BCBCR values could then be prioritized for further risk assessment. Using this method, two of the PFAS, PFOA (Perfluorooctanoic Acid) and PFOS (Perfluorooctane Sulfonic Acid), have BCBCR values < 1 for some populations. An additional 9 PFAS have BCBCR values < 100 for some populations. This study shows a promising approach to screening level risk assessments of compounds such as PFAS that are long-lived in humans and other species.
Open AccessA Comparison of In Vitro Points of Departure with Human Blood Levels for Per- and Polyfluoroalkyl Substances (PFAS)
Per- and polyfluoroalkyl substances (PFAS) are widely used, and their fluorinated state contributes to unique uses and stability but also long half-lives in the environment and humans. PFAS have been shown to be toxic, leading to immunosuppression, cancer, and other adverse health outcomes. Only a small fraction of the PFAS in commerce have been evaluated for toxicity using in vivo tests, which leads to a need to prioritize which compounds to examine further. Here, we demonstrate a prioritization approach that combines human biomonitoring data (blood concentrations) with bioactivity data (concentrations at which bioactivity is observed in vitro) for 31 PFAS. The in vitro data are taken from a battery of cell-based assays, mostly run on human cells. The result is a Bioactive Concentration to Blood Concentration Ratio (BCBCR), similar to a margin of exposure (MoE). Chemicals with low BCBCR values could then be prioritized for further risk assessment. Using this method, two of the PFAS, PFOA (Perfluorooctanoic Acid) and PFOS (Perfluorooctane Sulfonic Acid), have BCBCR values < 1 for some populations. An additional 9 PFAS have BCBCR values < 100 for some populations. This study shows a promising approach to screening level risk assessments of compounds such as PFAS that are long-lived in humans and other species.